These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 26782163)

  • 1. Kupffer Imaging by Contrast-Enhanced Sonography With Perfluorobutane Microbubbles Is Associated With Outcomes After Radiofrequency Ablation of Hepatocellular Carcinoma.
    Nuta J; Tamai H; Mori Y; Shingaki N; Maeshima S; Shimizu R; Maeda Y; Moribata K; Niwa T; Deguchi H; Inoue I; Maekita T; Iguchi M; Kato J; Ichinose M
    J Ultrasound Med; 2016 Feb; 35(2):359-71. PubMed ID: 26782163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Irregular Defects in Hepatocellular Carcinomas During the Kupffer Phase of Contrast-Enhanced Ultrasonography with Perfluorobutane Microbubbles: Pathological Features and Metastatic Recurrence After Surgical Resection.
    Nuta J; Shingaki N; Ida Y; Shimizu R; Hayami S; Ueno M; Fukatsu K; Itonaga M; Yoshida T; Maeda Y; Moribata K; Deguchi H; Maekita T; Iguchi M; Kato J; Yamaue H; Tamai H
    Ultrasound Med Biol; 2017 Sep; 43(9):1829-1836. PubMed ID: 28625558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of Contrast-Enhanced Sonography With Perfluorobutane Microbubbles for Diagnosis of Recurrent Hepatocellular Carcinoma.
    Shagdarsuren B; Tamai H; Shingaki N; Mori Y; Maeshima S; Nuta J; Maeda Y; Moribata K; Niwa T; Deguchi H; Inoue I; Maekita T; Iguchi M; Kato J; Ichinose M
    J Ultrasound Med; 2016 Jul; 35(7):1383-91. PubMed ID: 27208196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Real-time contrast-enhanced sonographically guided biopsy or radiofrequency ablation of focal liver lesions using perflurobutane microbubbles (sonazoid): value of Kupffer-phase imaging.
    Park HS; Kim YJ; Yu MH; Jung SI; Jeon HJ
    J Ultrasound Med; 2015 Mar; 34(3):411-21. PubMed ID: 25715362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis of hepatocellular carcinoma nodules in patients with chronic liver disease using contrast-enhanced sonography: usefulness of the combination of arterial- and kupffer-phase enhancement patterns.
    Suzuki K; Okuda Y; Ota M; Kojima F; Horimoto M
    J Ultrasound Med; 2015 Mar; 34(3):423-33. PubMed ID: 25715363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contrast-enhanced sonography-guided radiofrequency ablation for the local recurrence of previously treated hepatocellular carcinoma undetected by B-mode sonography.
    Miyamoto N; Hiramatsu K; Tsuchiya K; Sato Y
    J Clin Ultrasound; 2010 Sep; 38(7):339-45. PubMed ID: 20572066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of contrast-enhanced ultrasonography with Sonazoid in radiofrequency ablation for hepatocellular carcinoma.
    Masuzaki R; Shiina S; Tateishi R; Yoshida H; Goto E; Sugioka Y; Kondo Y; Goto T; Ikeda H; Omata M; Koike K
    J Gastroenterol Hepatol; 2011 Apr; 26(4):759-64. PubMed ID: 21054516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Usefulness of contrast-enhanced intraoperative ultrasound using Sonazoid in patients with hepatocellular carcinoma.
    Arita J; Takahashi M; Hata S; Shindoh J; Beck Y; Sugawara Y; Hasegawa K; Kokudo N
    Ann Surg; 2011 Dec; 254(6):992-9. PubMed ID: 21694582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Irregular vascular pattern by contrast-enhanced ultrasonography and high serum Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein level predict poor outcome after successful radiofrequency ablation in patients with early-stage hepatocellular carcinoma.
    Takada H; Tsuchiya K; Yasui Y; Nakakuki N; Tamaki N; Suzuki S; Nakanishi H; Itakura J; Takahashi Y; Kurosaki M; Asahina Y; Enomoto N; Izumi N
    Cancer Med; 2016 Nov; 5(11):3111-3120. PubMed ID: 27748052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiofrequency ablation guided by contrast harmonic sonography using perfluorocarbon microbubbles (Sonazoid) for hepatic malignancies: an initial experience.
    Minami Y; Kudo M; Hatanaka K; Kitai S; Inoue T; Hagiwara S; Chung H; Ueshima K
    Liver Int; 2010 May; 30(5):759-64. PubMed ID: 20456042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sonazoid-enhanced sonography for guiding radiofrequency ablation for hepatocellular carcinoma: better tumor visualization by Kupffer-phase imaging and vascular-phase imaging after reinjection.
    Miyamoto N; Hiramatsu K; Tsuchiya K; Sato Y; Terae S; Shirato H
    Jpn J Radiol; 2009 May; 27(4):185-93. PubMed ID: 19499310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of hepatocellular carcinoma by contrast-enhanced ultrasound with perfluorobutane microbubbles: comparison with dynamic CT.
    Mandai M; Koda M; Matono T; Nagahara T; Sugihara T; Ueki M; Ohyama K; Murawaki Y
    Br J Radiol; 2011 Jun; 84(1002):499-507. PubMed ID: 20959373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New contrast enhanced ultrasonography agent: impact of Sonazoid on radiofrequency ablation.
    Hiraoka A; Hiasa Y; Onji M; Michitaka K
    J Gastroenterol Hepatol; 2011 Apr; 26(4):616-8. PubMed ID: 21418298
    [No Abstract]   [Full Text] [Related]  

  • 14. Value of contrast-enhanced sonography of small hepatocellular carcinoma with sonazoid prior to radiofrequency ablation.
    Lee SJ; Won HJ; Kim KW; Shin YM; Kim PN
    J Clin Ultrasound; 2017 Sep; 45(7):383-390. PubMed ID: 28271531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of the ablated area by the spread of microbubbles during radiofrequency ablation of hepatocellular carcinoma.
    Nouso K; Shiraga K; Uematsu S; Okamoto R; Harada R; Takayama S; Kawai W; Kimura S; Ueki T; Okano N; Nakagawa M; Mizuno M; Araki Y; Shiratori Y
    Liver Int; 2005 Oct; 25(5):967-72. PubMed ID: 16162154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of contrast-enhanced ultrasound with Perfluorobutane in lesion detection, guidance for microwave ablation, and response assessment of hepatocellular carcinoma.
    Mukund A; Bansal A; Patidar Y; Thapar S; Sharma MK; Sarin SK
    Abdom Radiol (NY); 2022 Oct; 47(10):3459-3467. PubMed ID: 35842563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The arterial tumor enhancement pattern on contrast-enhanced computed tomography is associated with primary cancer death after radiofrequency ablation for small hepatocellular carcinoma.
    Shimizu R; Tamai H; Mori Y; Shingaki N; Maeshima S; Nuta J; Maeda Y; Moribata K; Muraki Y; Deguchi H; Inoue I; Maekita T; Iguchi M; Kato J; Ichinose M
    Hepatol Int; 2016 Mar; 10(2):328-39. PubMed ID: 26530813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ablation therapy guided by contrast-enhanced sonography with Sonazoid for hepatocellular carcinoma lesions not detected by conventional sonography.
    Numata K; Morimoto M; Ogura T; Sugimori K; Takebayashi S; Okada M; Tanaka K
    J Ultrasound Med; 2008 Mar; 27(3):395-406. PubMed ID: 18314518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrating contrast-enhanced sonography in the follow-up algorithm of hepatocellular carcinoma treated with radiofrequency ablation: single cancer center experience.
    Catalano O; Izzo F; Vallone P; Sandomenico F; Albino V; Nunziata A; Fusco R; Petrillo A
    Acta Radiol; 2015 Feb; 56(2):133-42. PubMed ID: 24523360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Planning Sonography Using Real-time Virtual Sonography and Contrast-enhanced Sonography for Radiofrequency Ablation of Inconspicuous Hepatocellular Carcinoma Nodules.
    Toshikuni N; Takuma Y; Tomokuni J; Yamamoto H
    Hepatogastroenterology; 2015 May; 62(139):661-6. PubMed ID: 26897949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.